{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:07:26Z","timestamp":1772172446477,"version":"3.50.1"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,2]]},"DOI":"10.1212\/wnl.46.2.413","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:17:46Z","timestamp":1336915066000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":96,"title":["Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease"],"prefix":"10.1212","volume":"46","author":[{"given":"M.","family":"Lehtovirta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Helisalmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mannermaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.-L.","family":"Helkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hanninen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ryynanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Sr.","given":"P. J.","family":"Riekkinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"4","volume":"35","year":"1985","unstructured":"Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985;35:453-461.","journal-title":"Neurology"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.1.1"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6410.9"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.5"},{"key":"e_1_3_1_6_2","first-page":"4","volume":"10","year":"1989","unstructured":"St. George-Hyslop PH, Myers RH, Haines JL, et al. Familial Alzheimer's disease: progress and problems. Neurobiol Aging 1989;10:417-427.","journal-title":"Neurobiol Aging"},{"key":"e_1_3_1_7_2","first-page":"7","volume":"349","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.","journal-title":"Nature"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.254.5028.9"},{"key":"e_1_3_1_9_2","first-page":"8","volume":"353","year":"1991","unstructured":"Chartier-Harlin MC, Crawford F, Houlden H, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991;353:844-846.","journal-title":"Nature"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0492-3"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-3"},{"key":"e_1_3_1_12_2","first-page":"6","volume":"258","year":"1992","unstructured":"Schellenberg GD, Bird T, Wijsman E, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671.","journal-title":"Science"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-3"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-3"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360103"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360103"},{"key":"e_1_3_1_17_2","first-page":"1","volume":"48","year":"1991","unstructured":"Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_19_2","first-page":"1","volume":"43","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.","journal-title":"Neurology"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91878-P"},{"key":"e_1_3_1_21_2","first-page":"7","volume":"34","year":"1993","unstructured":"Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.261.5117.9"},{"key":"e_1_3_1_23_2","first-page":"2","volume":"65","year":"1984","unstructured":"Utermann G, Kindermann I, Kaffarnik H, Steinmetrz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984;65:232-236.","journal-title":"Hum Genet"},{"key":"e_1_3_1_24_2","first-page":"3","volume":"3","year":"1983","unstructured":"Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary heart disease. Atherosclerosis 1983;3:310-315.","journal-title":"Atherosclerosis"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.1.1"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91066-A"},{"key":"e_1_3_1_27_2","first-page":"2","volume":"135","year":"1992","unstructured":"Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_28_2","first-page":"6","volume":"14","year":"1984","unstructured":"Breitner JCS, Folstein MF. Familial Alzheimer dementia: a prevalent disorder with specific clinical features. Psychol Med 1984;14:63-80.","journal-title":"Psychol Med"},{"key":"e_1_3_1_29_2","first-page":"1","volume":"149","year":"1992","unstructured":"Luchins DJ, Cohen D, Hanrahan P, et al. Are there clinical differences between familial and nonfamilial Alzheimer's disease? Am J Psychiatry 1992;149:1023-1027.","journal-title":"Are there clinical differences between familial and nonfamilial Alzheimer's disease? Am J Psychiatry"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"39","year":"1991","unstructured":"Edwards JK, Larson EB, Hughes JP, Kukull WA. Are there clinical and epidemiological differences between familial and non-familial Alzheimer's disease? J Am Geriatr Soc 1991;39:477-483.","journal-title":"Are there clinical and epidemiological differences between familial and non-familial Alzheimer's disease? J Am Geriatr Soc"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1983.04050010022005"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00819559"},{"key":"e_1_3_1_33_2","first-page":"9","volume":"34","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.","journal-title":"Neurology"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90017-5"},{"key":"e_1_3_1_35_2","first-page":"7","volume":"19","year":"1983","unstructured":"Reisberg B, Schneck MK, Ferris SH. The brief cognitive rating scale (BCRS): findings in primary degenerative dementia (PDD). Psychopharmacol Bull 1983;19:734-739.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_1_36_2","first-page":"2","volume":"5","year":"1968","unstructured":"Webster DD. Clinical analysis of the disability on Parkinson's disease. Mod Treat 1968;5:257-262.","journal-title":"Mod Treat"},{"key":"e_1_3_1_37_2","first-page":"5","volume":"23","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_38_2","first-page":"4","volume":"7","year":"1980","unstructured":"Rosen WG, Terry RD, Fuld PA, Katzman R, Beck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_39_2","first-page":"2","volume":"24","year":"1988","unstructured":"Helkala E-L, Laulumaa V, Soininen H, Riekkinen PJ. Recall and recognition on memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol 1988;24:214-217.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_40_2","first-page":"8","volume":"19","year":"1945","unstructured":"Wechsler D. A standardised memory scale for clinical use. J Psychol 1945;19:87-95.","journal-title":"J Psychol"},{"key":"e_1_3_1_41_2","first-page":"8","volume":"43","year":"1975","unstructured":"Russell EW. A multiple scoring method for assessment of complex memory functions. J Consult Clin Psychol 1975;43:800-809.","journal-title":"J Consult Clin Psychol"},{"key":"e_1_3_1_42_2","unstructured":"Kaplan E Goodglass H Weintraub S. The Boston naming test. Philadelphia: Lea and Febiger 1983."},{"key":"e_1_3_1_43_2","unstructured":"Wechsler D. WAIS-R manual. New York: Psychological Corporation 1981."},{"key":"e_1_3_1_44_2","unstructured":"Goodglass H Kaplan E. The assessment of aphasia and related disorders. Philadelphia: Lea and Febiger 1983."},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(76)80024-X"},{"key":"e_1_3_1_46_2","first-page":"2","volume":"8","year":"1958","unstructured":"Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.","journal-title":"Percept Mot Skills"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3932(67)90046-2"},{"key":"e_1_3_1_48_2","first-page":"5","volume":"31","year":"1990","unstructured":"Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_49_2","first-page":"5","volume":"121","year":"1993","unstructured":"Tsukamoto K, Watanabe T, Matsushima T, et al. Determination by PCR-RFLP of apoE genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_1_50_2","first-page":"6","volume":"67","year":"1995","unstructured":"Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala, and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995;67:65-72.","journal-title":"Neuroscience"},{"key":"e_1_3_1_51_2","first-page":"5","volume":"14","year":"1983","unstructured":"Heyman A, Wilkinson WE, Hurwitz BJ, et al. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol 1983;14:507-515.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_52_2","first-page":"1","volume":"149","year":"1981","unstructured":"Folstein MD, Breitner JCS. Language disorders predicts familial Alzheimer's disease. Johns Hopkins Med J 1981;149:145-147.","journal-title":"Johns Hopkins Med J"},{"key":"e_1_3_1_53_2","first-page":"6","volume":"309","year":"1994","unstructured":"Kuusisto J, Koivisto K, Mykkanen L, et al. Association of apolipoprotein E phenotypes with late-onset Alzheimer's disease: a population-based study. BMJ 1994;309:636-638.","journal-title":"BMJ"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90342-5"},{"key":"e_1_3_1_55_2","first-page":"6","volume":"54","year":"1994","unstructured":"Tsai M-S, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994;54:643-649.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.1370090103"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90700-M"},{"key":"e_1_3_1_58_2","first-page":"1","volume":"39","year":"1989","unstructured":"Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease. Clin Genet 1989;39:183-189.","journal-title":"Clin Genet"},{"key":"e_1_3_1_59_2","first-page":"3","volume":"9","year":"1990","unstructured":"Ferini-Strambi L, Smirne S, Garancini P, Pinto P, Franceschi M. Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: a case control study. Neuroepidemiology 1990;9:39-49.","journal-title":"Neuroepidemiology"},{"key":"e_1_3_1_60_2","first-page":"8","volume":"47","year":"1990","unstructured":"Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;47:847-850.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1982.tb03055.x"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.1.1"},{"key":"e_1_3_1_63_2","first-page":"9","volume":"12","year":"1974","unstructured":"Pearce J. The extrapyramidal disorder of Alzheimer's disease. Eur Neurol 1974;12:94-103.","journal-title":"Eur Neurol"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02257617"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"},{"key":"e_1_3_1_66_2","first-page":"4","volume":"14","year":"1993","unstructured":"Mullan M, Tsuji S, Miki T, et al. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-Ile mutation in the amyloid precursor protein gene. Neurobiol Aging 1993;14:407-419.","journal-title":"Neurobiol Aging"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.2.413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:10:59Z","timestamp":1711548659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.2.413"}},"subtitle":["Relation to apolipoprotein E polymorphism"],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1212\/WNL.46.2.413"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.2.413","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}